QR Code

CRISPR/Cas9-based Engineering of Immunoglobulin Loci in Hybridoma Cells

Development of the hybridoma technology by Köhler and Milstein (1975) has revolutionized the immunological field by enabling routine use of monoclonal antibodies (mAbs) in research and development efforts, resulting in their successful application in the clinic today. While recombinant good manufact...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Camille Le Gall, Felix Fennemann, Johan van der Schoot, Ferenc Scheeren, Martijn Verdoes
Format: Artigo
Langue:Inglês
Publié: Bio-protocol LLC 2023-02-01
Collection:Bio-Protocol
Accès en ligne:https://bio-protocol.org/en/bpdetail?id=4613&type=0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!